Home/Filings/4/0001181431-13-028736
4//SEC Filing

Sutcliffe Joyce A. 4

Accession 0001181431-13-028736

CIK 0001373707other

Filed

May 16, 8:00 PM ET

Accepted

May 17, 4:56 PM ET

Size

9.8 KB

Accession

0001181431-13-028736

Insider Transaction Report

Form 4
Period: 2013-05-15
Sutcliffe Joyce A.
Senior Vice President, Biology
Transactions
  • Award

    Employee Stock Option (right to buy)

    2013-05-15+70,91370,913 total
    Exercise: $7.94Exp: 2023-05-14Common Stock (70,913 underlying)
Footnotes (1)
  • [F1]Vests as to 25% of the shares on 5/15/2014. Further vests as to an additional 6.25% of the original grant on 8/15/2014 and at the end of each successive three-month period thereafter until 5/15/2017.

Issuer

TETRAPHASE PHARMACEUTICALS INC

CIK 0001373707

Entity typeother

Related Parties

1
  • filerCIK 0001572339

Filing Metadata

Form type
4
Filed
May 16, 8:00 PM ET
Accepted
May 17, 4:56 PM ET
Size
9.8 KB